ACRS
Aclaris Therapeutics, Inc.Company with tickers: ACRS
CIK
1557746
CUSIP
00461U105
Shares Outstanding
139,663,680
13F Activity (30d)
92 filings
90 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-06-05 | Molineaux Christopher P. |
Director | Convert | 11,580 |
| 2026-06-05 | MILANO VINCENT |
Director | Convert | 11,580 |
| 2026-06-05 | MILANO VINCENT |
Director | Convert | 11,580 |
| 2026-06-05 | Mehra Anand |
Director | Convert | 11,580 |
| 2026-06-05 | Mehra Anand |
Director | Convert | 11,580 |
| 2026-06-05 | Humphries William D. |
Director | Convert | 11,580 |
| 2026-06-05 | SCHIFF ANDREW N |
Director | Convert | 11,580 |
| 2026-06-05 | Molineaux Christopher P. |
Director | Convert | 11,580 |
| 2026-06-05 | GOWEN MAXINE |
Director | Convert | 11,580 |
| 2026-06-05 | Humphries William D. |
Director | Convert | 11,580 |
| 2026-06-05 | GOWEN MAXINE |
Director | Convert | 11,580 |
| 2026-06-05 | SCHIFF ANDREW N |
Director | Convert | 11,580 |
| 2026-06-04 | Mehra Anand |
Director | Award | 42,350 |
| 2026-06-04 | GOWEN MAXINE |
Director | Award | 10,987 |
| 2026-06-04 | Molineaux Christopher P. |
Director | Award | 10,987 |
| 2026-06-04 | Mehra Anand |
Director | Award | 10,987 |
| 2026-06-04 | MILANO VINCENT |
Director | Award | 10,987 |
| 2026-06-04 | MILANO VINCENT |
Director | Award | 42,350 |
| 2026-06-04 | SCHIFF ANDREW N |
Director | Other | 434,455 |
| 2026-06-04 | SCHIFF ANDREW N |
Director | Award | 42,350 |
| 2026-06-04 | Humphries William D. |
Director | Award | 10,987 |
| 2026-06-04 | GOWEN MAXINE |
Director | Award | 42,350 |
| 2026-06-04 | Molineaux Christopher P. |
Director | Award | 42,350 |
| 2026-06-04 | Humphries William D. |
Director | Award | 42,350 |
| 2026-06-04 | SCHIFF ANDREW N |
Director | Award | 10,987 |
| 2026-05-01 | Hall Jesse Wayne |
Chief Medical Officer | Convert | 36,375 |
| 2026-05-01 | Hall Jesse Wayne |
Chief Medical Officer | Convert | 36,375 |
| 2026-05-01 | Hall Jesse Wayne |
Chief Medical Officer | Tax | 9,330 |
| 2026-04-23 | Leonard Braden Michael |
Insider | Sell | 300,000 |
| 2026-03-01 | Balthaser Kevin |
Chief Financial Officer | Tax | 677 |
| 2026-03-01 | Balthaser Kevin |
Chief Financial Officer | Convert | 2,375 |
| 2026-03-01 | Balthaser Kevin |
Chief Financial Officer | Convert | 2,375 |
| 2026-02-03 | Walker Neal |
Director, CEO | Tax | 18,611 |
| 2026-02-03 | Balthaser Kevin |
Chief Financial Officer | Convert | 22,025 |
| 2026-02-03 | Loerop James |
EVP Business Development | Tax | 5,937 |
| 2026-02-03 | Balthaser Kevin |
Chief Financial Officer | Convert | 22,025 |
| 2026-02-03 | Davis Hugh M. |
Director, President and COO | Convert | 18,675 |
| 2026-02-03 | Loerop James |
EVP Business Development | Convert | 20,875 |
| 2026-02-03 | Balthaser Kevin |
Chief Financial Officer | Tax | 6,449 |
| 2026-02-03 | Walker Neal |
Director, CEO | Convert | 63,475 |
| 2026-02-03 | Davis Hugh M. |
Director, President and COO | Convert | 18,675 |
| 2026-02-03 | Walker Neal |
Director, CEO | Convert | 63,475 |
| 2026-02-03 | Loerop James |
EVP Business Development | Convert | 20,875 |
| 2026-02-02 | Hall Jesse Wayne |
Chief Medical Officer | Award | 343,300 |
| 2026-02-02 | Kolbeck Roland Wilhelm |
Chief Scientific Officer | Award | 95,700 |
| 2026-02-02 | Davis Hugh M. |
Director, President and COO | Award | 96,100 |
| 2026-02-02 | Hall Jesse Wayne |
Chief Medical Officer | Award | 98,100 |
| 2026-02-02 | Walker Neal |
Director, CEO | Award | 961,700 |
| 2026-02-02 | Davis Hugh M. |
Director, President and COO | Award | 336,300 |
| 2026-02-02 | Balthaser Kevin |
Chief Financial Officer | Award | 99,100 |
Showing 1–50 of 826 transactions